Two malaria vaccines are approved and several prophylactic antibodies are in development, but a combination of strategies tailored to different epidemiological situations will be needed if malaria is to be eliminated.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
World Health Organization. WHO Guidelines for Malaria 2023 https://go.nature.com/48zjClh (2023).
Nussenzweig, R. et al. Mil. Med. 134, 1176–1182 (1969).
Clyde, D. F. et al. Am. J. Med. Sci. 266, 169–177 (1973).
Gaudinski, M. R. et al. N. Engl. J. Med. 385, 803–814 (2021).
Wu, R. L. et al. N. Engl. J. Med. 387, 397–407 (2022).
Kayentao, K. et al. N. Engl. J. Med. 377, 1833–1842 (2022).
Williams, K. L. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02659-z (2024).
Regules, J. A. et al. J. Infect. Dis. 214, 732–772 (2016).
World Health Organization. World Malaria Report 2023 https://go.nature.com/48ummR6 (2023).
Kapulu, M. C. et al. JCI Insight 6, e146443 (2021).
World Health Organizaton. Monoclonal Antibodies for Malaria Prevention https://go.nature.com/3RLKwj0 (2023).
Stanisic, D. I. et al. BioDrugs 37, 737–756 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Taylor, T.E., Osier, F. Integrating vaccines and monoclonal antibodies into malaria prevention. Nat Med 30, 37–38 (2024). https://doi.org/10.1038/s41591-023-02745-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02745-2